Drug intelligence / Profile preview

mucuna pruriens endocarp

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Parenteral
01

Overview

Mucuna pruriens endocarp refers specifically to the dried or extracted inner layer of the seed (endocarp) of the plant Mucuna pruriens, commonly known as Velvet Bean. This material has been used in Ayurvedic medicine to treat Parkinson’s disease due to its significant **levodopa (L-DOPA) content**, a precursor of dopamine and a principal treatment for Parkinsonism. Preclinical and clinical studies indicate that Mucuna pruriens endocarp exerts anti-parkinsonian effects—a water extract or powder improves motor function, likely via natural levodopa and possibly other yet unidentified compounds. Unlike synthetic levodopa products, Mucuna pruriens endocarp appears to have a reduced risk of inducing drug-induced dyskinesias (involuntary movements), potentially due to slower absorption, additional neuroactive compounds, or other mechanisms intrinsic to the plant matrix. Its mechanism involves **dopaminergic neurotransmission enhancement** through natural levodopa supply and potential antioxidative effects, with the possible presence of other neuroprotective phytoconstituents. In research, Mucuna pruriens endocarp has shown efficacy in animal models and human trials; one proprietary formulation ("HP-200") has been used in clinical investigations[1][2][4][5].

Brand names
HP-200HP200HP 200
Other names
mucuna pruriens seed endocarpvelvet bean endocarpmucuna pruriens endocarp powder
02

Targets

DRD2 (Dopamine D2 Receptor)DDC (Aromatic L-amino acid decarboxylase)Acetylcholinesterase

Beyond the preview

Go deeper on mucuna pruriens endocarp.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mucuna pruriens endocarp.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call